Congratulations to Assoc. Prof. Dr. Gerda Egger and Dr. Raheleh Sheibani from the Molecular Pathology program line of the LBI:AD! They received a FWF stand-alone grant for the project “The biological role of PSMA for prostate cancer”. The project focuses on the biological function of prostate specific membrane antigen (PSMA). Go and read more about […]
The MIC Festival of the Medical Imaging Cluster (MIC) of the Medical University of Vienna took place last week on June, 6th 2019. This year’s motto was Digital Revolution in Medical Imaging, highlighting the ever growing importance of big data, digitalization and computational analysis and their translation to clinical routine and research. Just as last […]
A bit over one year after meeting with our Scientific Advisory Board (SAB) for the first time, our LBI:AD had their second meeting with the SAB last week on the 13th of May 2019. The SAB consists of five internationally renowned experts, which were again invited to review our institute’s research, to evaluate our progress […]
The LBG Meeting for Health Sciences 2018 took place in Vienna on the 29th and 30th of November. The focus was on the translation of research results from theory into practice. Therefore, researchers were asked to submit abstracts for presentation on preclinical, clinical or implementation research with emphasis on Cardiovascular research, Haematology and cancer research, […]
This podcast with Professor Gerda Egger (Department of Pathology, Medical University of Vienna and Ludwig Boltzmann Institute Applied Diagnostics) provides an overview of the current routinely used biomarkers as well as an outlook on what is on the horizon in epigenetic biomarkers.
Gerda Egger, Deputy and Head of Molecular Pathology, attended the first conference of the Arab Genetic Research Association. It was organised by Princess Al Jawhara Al Ibrahim Center at the Arabian Gulf University under the title “Human Genetics, Epigenetics, and Personalised Genomics”. The conference discussed the latest and most important topics related to genetics, epigenetics, and […]
On February the 1st, 2018 our first Scientific Advisory Board Meeting took place. Five internationally renowned experts visited our institute with the purpose to evaluate and review our research.The meeting started with a welcome note by Vice Rector Dipl.-Ing. Dr Michaela Fritz. She emphasised the importance of personalised and translational medicine as well as the […]
With a quite big team of already 14 employees, the LBI Applied Diagnostics decided to be ready to celebrate its inauguration on the 2nd of May 2017. For this occasion, nothing less than the stunning location, Wolke 21 was chosen which is situated in Vienna’s 22nd district. The impressive location provided a delightful view from […]
On the 21th December 2016, the LBI Applied Diagnostics held its first Board of Partners Meeting in the famous Viennese Adolf Looshaus with a subsequent historical tour. Happily, all partners were represented physically or via dial-in possibility. Therefore, important decisions about the future of the institute could be made. We are happy to announce that […]
Die Vorstellung des Institutes erfolgte im Rahmen des Weinherbstes der Ludwig Boltzmann Gesellschaft am 20. Oktober 2015 im Beisein des Präsidenten der Ludwig Boltzmann Gesellschaft, DI Josef Pröll.Neues Ludwig Boltzmann Institut für Angewandte Diagnostik am AKH: „Liquid Biopsies“ und „Imaging Biomarker“ werden kombiniert, um eine neue zielgerichtete Molekulare Bildgebung zu ermöglichen Der wissenschaftliche Fokus des […]
